MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Scales"

  • 2022 International Congress

    Classification of extremity movements by visual observation of signal transforms

    J. Brasic, L. Ziegelman, T. Kosuri, H. Hakim, L. Zhao, A. Gokce, K. Mathur, M. Hernandez, K. Mills (Baltimore, USA)

    Objective: To create a tool for raters certified in the MDS-UPDRS) [1] to blindly score online signal transforms of the output of the wearable sensors to…
  • 2022 International Congress

    Use of virtual reality devices for the monitoring of Parkinson’s disease

    S. Hirczy, M. Salinas (Dallas, USA)

    Objective: To determine whether mass market virtual reality (VR) devices can be used to detect the motor manifestations of Parkinson’s disease and their response to…
  • 2022 International Congress

    Multi-modal MRI features and their relationship with clinical scales in Parkinson disease and Atypical Parkinsonian Syndromes

    H. Martinez-Hernandez, D. Lopez-Mena, B. Candela-Solano, A. Medina-Islas, L. Alvarez, I. Acosta (Mexico City, Mexico)

    Objective: To compare MRI sings and volumetric measurements in Parkinson disease (PD), Progressive Supranuclear Palsy (PSP), and Multiple System Atrophy (MSA) and their relationship with…
  • MDS Virtual Congress 2021

    Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme

    H. Tang, T. van Eimeren, C. Sampaio, T. Mestre (Ottawa, Canada)

    Objective: To review studies for disease progression biomarkers published in HD and evaluate their methodological quality in a standardized manner. Background: Huntington disease (HD) is a fatal autosomal dominant neurodegenerative condition that starts to manifest clinically around the 4th decade of life. There are promising novel genetic-based therapies under development intended to modify the disease trajectory. Valid…
  • MDS Virtual Congress 2021

    The impact of gender identity and gender role orientation on health-related quality of life in people with Parkinson’s disease.

    I. Göttgens, S. Darweesh, B. Bloem, S. Oertelt-Prigione (Nijmegen, Netherlands)

    Objective: To assess the associations of gender identity and gender role orientation with health-related quality of life (HRQoL) among persons with Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Relationship of satisfaction and adherence in remote digital monitoring: Results from a clinical drug trial in early Parkinson’s disease

    B. Fehlmann, A. Thomann, W. Popp, F. Lipsmeier, E. Volkova-Volkmar, J. Friess, H. Svoboda, G. Pagano, T. Kilchemann, A. Bamdadian, W. Zago, R. Postuma, M. Lindemann, K. Taylor (Basel, Switzerland)

    Objective: To investigate satisfaction with daily remote monitoring with a digital health technology tool (DHTT) in individuals with early Parkinson’s disease (PD) and the relationship…
  • MDS Virtual Congress 2021

    Emergence of new symptoms in experiences of daily living in early Parkinson’s disease

    J. Cedarbaum, M. Tosin, T. Simuni, G. Stebbins (Woodbridge, USA)

    Objective: To explore the utility of assessing emergence of new symptoms (ES) impacting the daily experiences of patients with early Parkinson’s disease (PD) in relation…
  • MDS Virtual Congress 2021

    The Role of the PD Diary Trainer/Reviewer in Parkinson’s Disease Clinical Trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To examine the experience profile of PD Diary raters in clinical trials Background: The Parkinson’s Disease (PD) Home Diary (Hauser, 2000)1 is a widely…
  • MDS Virtual Congress 2021

    Does MDS-UPDRS provide greater sensitivity to mild disease than UPDRS for assessing motor severity in early Parkinson’s disease?

    D. Hall, M. Tosin, C. Patterson, G. Stebbins (Chicago, USA)

    Objective: To test whether The Movement Disorder Society revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III (Motor Examination) items provide increased sensitivity…
  • MDS Virtual Congress 2021

    The Hauser Diary knowledge test as a tool to improve Rater Training Programs in Parkinson’s disease clinical trials

    C. Mañeru, S. Meyer (Barcelona, Spain)

    Objective: To identify the areas with specific training needs for Rater Training Programs (RTP) on the Hauser Diary in Parkinson’s disease (PD) clinical trials Background:…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 35
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley